Evelyne Bischof
InvestorAdvisory Board Member at LongeVC
About
Evelyne Bischof (MD, MHP, FEFIM) is an Advisory Board member at LongeVC and Chairman of the Longevity Science Foundation Visionary Board. She is a longevity physician at Human Longevity, Inc., specializing in internal medicine and oncology with a focus on preventative and precision medicine, biogerontology, and geronto-oncology, and works on AI applications in biomedical research. Harvard- and Columbia-trained, she has held academic and clinical roles at institutions including Shanghai Jiao Tong University School of Medicine, University Hospital Basel, and University Hospital Zürich, and has authored more than 40 peer-reviewed papers.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechDigital HealthLongevity
Colleagues at LongeVC
Alex Zhavoronkov
Venture Partner at LongeVC
Artem Trotsyuk
Operating Partner - US at LongeVC
Artemy Shumskiy
Principal at LongeVC
Christine Yuan Huang
Advisory Board at LongeVC
Dr. Weigao Wang
Venture Fellow at LongeVC
Evgeny Izumchenko
Venture Partner at LongeVC
Garri Zmudze
Managing Partner at LongeVC
Gege Qian
Venture Fellow (2023 Class) at LongeVC
Frequently asked questions
- Who is Evelyne Bischof?
- Evelyne Bischof (MD, MHP, FEFIM) is an Advisory Board member at LongeVC and Chairman of the Longevity Science Foundation Visionary Board. She is a longevity physician at Human Longevity, Inc., specializing in internal medicine and oncology with a focus on preventative and precision medicine, biogerontology, and geronto-oncology, and works on AI applications in biomedical research. Harvard- and Columbia-trained, she has held academic and clinical roles at institutions including Shanghai Jiao Tong University School of Medicine, University Hospital Basel, and University Hospital Zürich, and has authored more than 40 peer-reviewed papers.
- Where does Evelyne Bischof work?
- Evelyne Bischof is Advisory Board Member at LongeVC.
- What does Evelyne Bischof invest in?
- Evelyne Bischof invests in AI & Machine Learning, Biotech, Digital Health, Longevity.